Council for europe portal
Language : en Search
Choose language

Newsroom

Certification of suitability (CEP) / Procedure of certification (general) | News | 08 August 2019 | Strasbourg, France
The latest monthly activity report for the Certification of Substances Department (DCEP) is now available.
Certification of suitability (CEP) / Procedure of certification (general) | News | 22 July 2019 | Strasbourg, France
CEP holders are invited to update their applications according to the revised monographs that will be implemented on the 1st of January 2020 in the 10th Edition of the Ph. Eur., and to follow the instructions given in the document.
Certification of suitability (CEP) / Procedure of certification (general) | News | 17 July 2019 | Strasbourg, France
The EDQM has revised the following documents to reflect current practice and clarify a couple of items: - Terms of reference; - Code of Practice for the Certification procedure.
Certification of suitability (CEP) / Procedure of certification (general) | News | 15 July 2019 | Strasbourg, France
According to the EDQM roadmap for electronic submissions for CEP applications, a major change will be implemented as of 1 January 2020: • eCTD will become mandatory for all CEP applications. • EDQM will stop accepting NeeS submissions for notifications, revisions and renewal applications. Therefore, all such submissions need to be in eCTD format.
EDQM / All activities | News | 09 July 2019 | Strasbourg, France
The international conference “EDQM & European Pharmacopoeia: State-of-the-Art Science for Tomorrow’s Medicines” took place on 19 to 20 June 2019 in Strasbourg to mark the publication of the 10th Edition of the European Pharmacopoeia (Ph. Eur.) and the 25th Anniversary of the European OMCL Network and of the Certification of Suitability Procedure.
European Pharmacopoeia / Public enquiry | News | 08 July 2019 | Strasbourg, France
Users of CEPs are invited to provide comments on draft monographs published in Pharmeuropa 31.3 before 30 September 2019.
Certification of suitability (CEP) / Procedure of certification (general) | News | 18 June 2019 | Strasbourg, France
The EDQM has now finalised the review and update of the vast majority of CEP dossiers for sartans containing a tetrazole ring structure. The CEP dossiers have been assessed following a risk- and science-based approach. When sufficient data was given to demonstrate that there were no risks of presence of nitrosamines and a limit in the specification of the active substance was not necessary (based...
European Pharmacopoeia / Monograph | News | 13 June 2019 | Strasbourg, France
The European Commission has issued its final legally binding decision on medicines containing valsartan, candesartan, irbesartan, losartan and olmesartan on 2 April 2019. This decision was based on the scientific assessment of angiotensin-II-receptor antagonists (sartans) containing a tetrazole group performed by the Committee for Medicinal Products for Human Use (CHMP), the conclusions of which...
EDQM / All activities | News | 06 June 2019 | Strasbourg, France
The latest EDQM Annual Report provides an overview of its accomplishments. In 2018 much was accomplished in the field of setting quality standards for the manufacture and control of medicines in Europe and beyond.
Certification of suitability (CEP) / Good manufacturing practice (GMP) | News | 09 May 2019 | Strasbourg, France
A review of data from API inspections conducted by the EDQM between 2006 and 2018 is now available.